Sign Up to like & get
recommendations!
1
Published in 2023 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.1218
Abstract: Voriconazole is a first‐line medicine for treating invasive aspergillosis. We aimed to evaluate the bioequivalence (BE) of voriconazole injection in Chinese healthy volunteers (HVs). In this single‐center, randomized, single‐dose, 2‐cycle, fasting‐dose BE study, HVs (n…
read more here.
Keywords:
time;
bioequivalence voriconazole;
concentration;
voriconazole injection ... See more keywords